Clearmind Medicine Inc. (NASDAQ:CMND) Sees Significant Growth in Short Interest

Clearmind Medicine Inc. (NASDAQ:CMND) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 217,400 shares, a growth of 7.9% from the September 30th total of 201,400 shares. Currently, 7.2% of the shares of the stock are short sold. Based on an average trading volume of 392,600 shares, the short-interest ratio is currently 0.6 days.

Clearmind Medicine Stock Performance

NASDAQ CMND opened at $1.39 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01. The firm’s 50 day simple moving average is $1.35 and its 200 day simple moving average is $1.34. Clearmind Medicine has a 1 year low of $0.92 and a 1 year high of $6.80.

Clearmind Medicine (NASDAQ:CMND) last posted its quarterly earnings results on Monday, September 16th. The company reported ($0.59) earnings per share (EPS) for the quarter.

Institutional Trading of Clearmind Medicine

A hedge fund recently bought a new stake in Clearmind Medicine stock. Cornerstone Wealth Group LLC bought a new stake in Clearmind Medicine Inc. (NASDAQ:CMND) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 20,000 shares of the company’s stock, valued at approximately $34,000. Cornerstone Wealth Group LLC owned approximately 1.18% of Clearmind Medicine at the end of the most recent reporting period. Hedge funds and other institutional investors own 96.05% of the company’s stock.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.